Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
324
Value
$5.19K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TAK by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026324$5.19K<0.1%00.0%UnchangedHolders
Q1 2026324$6.00K<0.1%00.0%UnchangedHolders
Q4 2025324$5.05K<0.1%00.0%UnchangedHolders
Q3 2025324$4.74K<0.1%00.0%UnchangedHolders
Q2 2025324$5.01K<0.1%00.0%UnchangedHolders
Q1 2025324$4.82K<0.1%00.0%UnchangedHolders
Q4 2024324$4.29K<0.1%00.0%UnchangedHolders
Q3 2024324$4.61K<0.1%−1,045,547−100.0%ReducedHolders
Q2 20241,045,871$13.5M<0.1%−1,200,878−53.4%ReducedHolders
Q1 20242,246,749$31.2M<0.1%−199,193−8.1%ReducedHolders
Q4 20232,445,942$34.9M<0.1%−1,313,556−34.9%ReducedHolders
Q3 20233,759,498$58.2M0.1%−71,257−1.9%ReducedHolders
Q2 20233,830,755$60.2M0.1%−77,980−2.0%ReducedHolders
Q1 20233,908,735$64.4M0.1%+72,745+1.9%AddedHolders
Q4 20223,835,990$59.8M0.1%−158,054−4.0%ReducedHolders
Q3 20223,994,044$51.8M0.1%−73,946−1.8%ReducedHolders
Q2 20224,067,990$57.1M0.1%−153,391−3.6%ReducedHolders
Q1 20224,221,381$60.5M0.1%+478,256+12.8%AddedHolders
Q4 20213,743,125$51.0M<0.1%−953,998−20.3%ReducedHolders
Q3 20214,697,123$76.9M0.1%−43,589−0.9%ReducedHolders
Q2 20214,740,712$79.8M0.1%+439,437+10.2%AddedHolders
Q1 20214,301,275$78.5M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.